Japan's biggest drugmaker said it will incur restructuring costs of about 140 billion yen ($899 million) this fiscal year as part of a plan to optimise its workforce, cut costs and strengthen technology
HHS's COVID-19 vaccination campaign saved $732 billion by averting illness and related costs during the Delta and Omicron variant waves, with a return of nearly $90 for every dollar spent.
Amneal Pharmaceuticals will pay more than $270 million to resolve claims it helped fuel the opioid epidemic, becoming the latest drug company to settle lawsuits over the addiction crisis.